Author's posts
Pfizer Beats Earnings And Addresses Drug Pricing, Rebates
Pfizer chief executive Ian Read said Tuesday that he sees a “huge sense of urgency” from the Trump administration to eliminate the existing safe harbor for drug rebates.
Ahead Of Second Quarter Earnings Call, Gilead CEO Resigns
Just before Gilead Sciences released its second quarter earnings Wednesday after the close of markets, the company announced in a separate statement that CEO John Milligan has resigned.
AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer’s With Immunotherapy
With backing from some of biotech’s biggest players, Alector, a startup taking on Alzheimer’s disease announced Wednesday that it has raised $133 million in a Series E funding round.
Stryker Beats Earnings Estimates, Barely Beats Revenue Estimates
Stryker’s shares were down about 2.5% in after hours trading following the release of its second quarter earnings Tuesday.
Eli Lilly Beats Earnings, Plans Animal Health IPO
Eli Lilly announced it plans to file an initial public offering for its multi-billion dollar sales animal health business, Elanco. Shares of the Indianapolis-based company were up 3.5% following the news released before its second quarter earnings call…
Intuitive Surgical Beats Expectations, Driven By da Vinci System
Intuitive Surgical again beat revenue and earnings expectations with the help of its da Vinci robotic surgical systems when it reported its second quarter performance after the market closed Thursday.
Bill Gates Announces Further Investment In Alzheimer’s Research, Taking On Disease Detection
Microsoft cofounder Bill Gates revealed more of his plan to invest in Alzheimer’s disease research on Tuesday.
Cancer Drugs Drive Johnson & Johnson’s Latest Quarter
Johnson & Johnson reported second quarter earnings Tuesday.
32-Year-Old Founder Sells His Pharmacy Startup To Amazon
Amazon announced Thursday that it has agreed to acquire startup PillPack.
